A Study To Assess The Pharmacokinetics Of Different Modified Release Formulations Of GSK221149 In Healthy Adult Subjects

NCT00449709 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Obstetric Labour, Premature
Premature Ejaculation

Interventions

DRUG: GSK221149

Sponsor

GlaxoSmithKline